Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 07, 2025 Filed Jan 11, 2025 02:02 UTC |
Giroux RichardCFO & COO
|
Exercise / conversionOrdinary Shares | 52,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001334 · form4-01112025_020102.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 889,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 22:54 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
PurchaseOrdinary Shares | 1,250,000 | $4.00 | $5,000,000.00 |
DisclosureSEC source: 0001062993-24-015109 · form4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 12,531,103 F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 06, 2024 Filed Jun 6, 2024 20:44 UTC |
Yu DebraDirector
|
GrantRestricted Share Units · Derivative | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015783 · form4-06062024_080610.xml · derivative · entry 1 Yu Debra · CIK 0001869480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Ordinary Shares · 45,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. Read SEC document |
| June 06, 2024 Filed Jun 6, 2024 20:42 UTC |
Mendoza NeilDirector
|
GrantRestricted Share Units · Derivative | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015780 · form4-06062024_080623.xml · derivative · entry 1 Mendoza Neil · CIK 0001742502 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Ordinary Shares · 45,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. Read SEC document |
| June 06, 2024 Filed Jun 6, 2024 20:43 UTC |
SHENK THOMAS EDirector
|
GrantRestricted Share Units · Derivative | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015782 · form4-06062024_080627.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Ordinary Shares · 45,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. Read SEC document |
| June 06, 2024 Filed Jun 6, 2024 20:41 UTC |
Indyk MartinDirector
|
GrantRestricted Share Units · Derivative | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015779 · form4-06062024_080645.xml · derivative · entry 3 Indyk Martin · CIK 0001766997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Ordinary Shares · 45,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F3 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. F3 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. Read SEC document |
| June 06, 2024 Filed Jun 6, 2024 20:42 UTC |
Seligman NicoleDirector
|
GrantRestricted Share Units · Derivative | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015781 · form4-06062024_080653.xml · derivative · entry 1 Seligman Nicole · CIK 0001683100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Ordinary Shares · 45,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. Read SEC document |
| June 06, 2024 Filed Jun 6, 2024 20:41 UTC |
Hukkelhoven EllenDirector
|
GrantRestricted Share Units · Derivative | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015778 · form4-06062024_080613.xml · derivative · entry 1 Hukkelhoven Ellen · CIK 0001743337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Ordinary Shares · 45,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. Read SEC document |
| June 06, 2024 Filed Jun 6, 2024 20:40 UTC |
Harris Keith R.Director
|
GrantRestricted Share Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015777 · form4-06062024_080641.xml · derivative · entry 3 Harris Keith R. · CIK 0001742703 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Ordinary Shares · 75,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F3 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. F3 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 22:48 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
GrantRestricted Share Units · Derivative | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-012219 · form4.xml · derivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 45,000 Underlying: Ordinary Shares · 45,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share of the Issuer upon settlement. The restricted share units become settleable when Ellen Hukkelhoven ("Ms. Hukkelhoven") ceases to be a director of the Issuer. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. F3 · ownership.nature: Ms. Hukkelhoven is a Managing Director of Perceptive Advisors, LLC (the "Advisor"). The Advisor serves as the investment manager of Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). The Advisor may be deemed to have an indirect pecuniary interest in the securities reported herein because the Advisor has the right to receive the director compensation provided in respect of Ms. Hukkelhoven's board service through a partial management fee offset. Joseph Edelman ("Mr. Edelman") is the managing member of the Advisor. Each of Mr. Edelman, the Master Fund and the Advisor disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman, the Master Fund or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 20:41 UTC |
Indyk MartinDirector
|
Exercise / conversionRestricted Share Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015779 · form4-06062024_080645.xml · derivative · entry 2 Indyk Martin · CIK 0001766997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: The restricted share units vest in a single annual installment upon the earlier of (i) June 8, 2024 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2024. F2 · derivative.expiration_date: The restricted share units vest in a single annual installment upon the earlier of (i) June 8, 2024 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2024. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 20:41 UTC |
Indyk MartinDirector
|
Exercise / conversionOrdinary Shares | 20,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-015779 · form4-06062024_080645.xml · nonDerivative · entry 1 Indyk Martin · CIK 0001766997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 20:40 UTC |
Harris Keith R.Director
|
Exercise / conversionRestricted Share Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015777 · form4-06062024_080641.xml · derivative · entry 2 Harris Keith R. · CIK 0001742703 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: The restricted share units vest in a single annual installment upon the earlier of (i) June 8, 2024 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2024. F2 · derivative.expiration_date: The restricted share units vest in a single annual installment upon the earlier of (i) June 8, 2024 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2024. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 20:40 UTC |
Harris Keith R.Director
|
Exercise / conversionOrdinary Shares | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-015777 · form4-06062024_080641.xml · nonDerivative · entry 1 Harris Keith R. · CIK 0001742703 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| May 28, 2024 Filed May 30, 2024 20:48 UTC |
Giroux RichardCFO & COO
|
GiftOrdinary Shares | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014895 · form4-05302024_080552.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 837,426 Read SEC document |
| April 05, 2024 Filed Apr 8, 2024 20:53 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
GiftOrdinary Shares | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010497 · form4-04082024_080428.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,372,504 Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 20:51 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
GiftOrdinary Shares | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008008 · form4-03142024_080323.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,373,504 Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 23:10 UTC |
Giroux RichardCFO & COO
|
GiftOrdinary Shares | 13,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-006380 · form4-03042024_110352.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 840,426 Read SEC document |
| January 17, 2024 Filed Jan 18, 2024 00:13 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
GrantRestricted Share Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001429 · form4-01182024_120126.xml · derivative · entry 4 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Ordinary Shares · 100,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F4 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 17, 2024 Filed Jan 18, 2024 00:16 UTC |
Giroux RichardCFO & COO
|
GrantRestricted Share Units · Derivative | 620,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001433 · form4-01182024_120118.xml · derivative · entry 6 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 620,000 Underlying: Ordinary Shares · 620,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F4 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 17, 2024 Filed Jan 18, 2024 00:15 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
GrantRestricted Share Units · Derivative | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001432 · form4-01182024_120128.xml · derivative · entry 5 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Ordinary Shares · 70,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F5 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F5 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 17, 2024 Filed Jan 18, 2024 00:15 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $6.16 | $0.00 |
DisclosureSEC source: 0001415889-24-001432 · form4-01182024_120128.xml · derivative · entry 4 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires 2034-01-17 F4 · derivative.exercise_date: The option vests as to one quarter of the total grant on January 17, 2025 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| January 17, 2024 Filed Jan 18, 2024 00:14 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
GrantRestricted Share Units · Derivative | 620,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001431 · form4-01182024_120152.xml · derivative · entry 5 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 620,000 Underlying: Ordinary Shares · 620,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F4 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 17, 2024 Filed Jan 18, 2024 00:14 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
GrantRestricted Share Units · Derivative | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001430 · form4-01182024_120104.xml · derivative · entry 4 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Ordinary Shares · 150,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F4 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:13 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Exercise / conversionRestricted Share Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001429 · form4-01182024_120126.xml · derivative · entry 3 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Ordinary Shares · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:13 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Tax withholdingOrdinary Shares | 2,644 | $6.36 | $16,815.84 |
DisclosureSEC source: 0001415889-24-001429 · form4-01182024_120126.xml · nonDerivative · entry 2 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,137 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:13 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Exercise / conversionOrdinary Shares | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-001429 · form4-01182024_120126.xml · nonDerivative · entry 1 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:16 UTC |
Giroux RichardCFO & COO
|
Exercise / conversionRestricted Share Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001433 · form4-01182024_120118.xml · derivative · entry 5 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:16 UTC |
Giroux RichardCFO & COO
|
Tax withholdingOrdinary Shares | 13,219 | $6.36 | $84,072.84 |
DisclosureSEC source: 0001415889-24-001433 · form4-01182024_120118.xml · nonDerivative · entry 2 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 853,926 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:16 UTC |
Giroux RichardCFO & COO
|
Exercise / conversionOrdinary Shares | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-001433 · form4-01182024_120118.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 867,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:15 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Exercise / conversionRestricted Share Units · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001432 · form4-01182024_120128.xml · derivative · entry 3 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Ordinary Shares · 37,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:15 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Tax withholdingOrdinary Shares | 14,756 | $6.36 | $93,848.16 |
DisclosureSEC source: 0001415889-24-001432 · form4-01182024_120128.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,724 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:15 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Exercise / conversionOrdinary Shares | 37,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-001432 · form4-01182024_120128.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:14 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Share Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001431 · form4-01182024_120152.xml · derivative · entry 4 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:14 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Tax withholdingOrdinary Shares | 15,863 | $6.36 | $100,888.68 |
DisclosureSEC source: 0001415889-24-001431 · form4-01182024_120152.xml · nonDerivative · entry 2 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,375,504 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:14 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Exercise / conversionOrdinary Shares | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-001431 · form4-01182024_120152.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,391,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:14 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Exercise / conversionRestricted Share Units · Derivative | 23,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001430 · form4-01182024_120104.xml · derivative · entry 3 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,750 Underlying: Ordinary Shares · 23,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:14 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Tax withholdingOrdinary Shares | 11,163 | $6.36 | $70,996.68 |
DisclosureSEC source: 0001415889-24-001430 · form4-01182024_120104.xml · nonDerivative · entry 2 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 564,329 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:14 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Exercise / conversionOrdinary Shares | 23,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-001430 · form4-01182024_120104.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 575,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 22:25 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Exercise / conversionRestricted Share Units · Derivative | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000865 · form4-01092024_100151.xml · derivative · entry 6 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 40,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F4 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 8, 2020. F4 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 8, 2020. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 22:25 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Tax withholdingOrdinary Shares | 18,800 | $6.63 | $124,644.00 |
DisclosureSEC source: 0001415889-24-000865 · form4-01092024_100151.xml · nonDerivative · entry 4 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 551,742 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 22:25 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Exercise / conversionOrdinary Shares | 40,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-000865 · form4-01092024_100151.xml · nonDerivative · entry 3 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 570,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of restricted share units granted on January 8, 2020. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 22:25 UTC |
Giroux RichardCFO & COO
|
Exercise / conversionRestricted Share Units · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000864 · form4-01092024_100155.xml · derivative · entry 8 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 37,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F4 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 8, 2020. F4 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 8, 2020. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 22:25 UTC |
Giroux RichardCFO & COO
|
Tax withholdingOrdinary Shares | 19,829 | $6.63 | $131,466.27 |
DisclosureSEC source: 0001415889-24-000864 · form4-01092024_100155.xml · nonDerivative · entry 4 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 842,145 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 22:25 UTC |
Giroux RichardCFO & COO
|
Exercise / conversionOrdinary Shares | 37,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-000864 · form4-01092024_100155.xml · nonDerivative · entry 3 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 861,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of restricted share units granted on January 8, 2020. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 22:23 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Share Units · Derivative | 48,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000863 · form4-01092024_100141.xml · derivative · entry 7 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 48,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F6 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 8, 2020. F6 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 8, 2020. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 22:23 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Tax withholdingOrdinary Shares | 25,777 | $6.63 | $170,901.51 |
DisclosureSEC source: 0001415889-24-000863 · form4-01092024_100141.xml · nonDerivative · entry 4 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,361,367 F5 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 22:23 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Exercise / conversionOrdinary Shares | 48,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-000863 · form4-01092024_100141.xml · nonDerivative · entry 3 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,387,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Represents vesting of one-quarter of restricted share units granted on January 8, 2020. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 07, 2024 Filed Jan 9, 2024 22:26 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Exercise / conversionRestricted Share Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000866 · form4-01092024_100139.xml · derivative · entry 3 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-half of restricted share units granted on January 7, 2022. F1 · derivative.expiration_date: Represents vesting of one-half of restricted share units granted on January 7, 2022. Read SEC document |
| January 07, 2024 Filed Jan 9, 2024 22:26 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Tax withholdingOrdinary Shares | 7,931 | $6.30 | $49,965.30 |
DisclosureSEC source: 0001415889-24-000866 · form4-01092024_100139.xml · nonDerivative · entry 2 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,781 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.